Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Van Lint

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Cancer Research|December 1, 2017
Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination TreatmentsAnje Cauwels, Sandra Van Lint, Franciane Paul, et al.
Cytotherapy|October 26, 2021
Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trialsJoline Ingels, Laurenz De Cock, Rupert L Mayer, et al.
Nature Communications|May 7, 2026
Ferroptosis-armed dendritic cell vaccines for glioma immunotherapyMariia Saviuk, Victoria D Turubanova, Sara De Brée, et al.
Cell Reports. Medicine|April 16, 2024
Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrumJoline Ingels, Laurenz De Cock, Dieter Stevens, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Inherited human TFIIIA deficiency disrupts T cell developmentEvi Duthoo, Sueun Park, Tamara Jarayseh, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Cancer Research|December 1, 2017
Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination TreatmentsAnje Cauwels, Sandra Van Lint, Franciane Paul, et al.
Cytotherapy|October 26, 2021
Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trialsJoline Ingels, Laurenz De Cock, Rupert L Mayer, et al.
Nature Communications|May 7, 2026
Ferroptosis-armed dendritic cell vaccines for glioma immunotherapyMariia Saviuk, Victoria D Turubanova, Sara De Brée, et al.
Cell Reports. Medicine|April 16, 2024
Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrumJoline Ingels, Laurenz De Cock, Dieter Stevens, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Inherited human TFIIIA deficiency disrupts T cell developmentEvi Duthoo, Sueun Park, Tamara Jarayseh, et al.
Pageof 4